Innovative Stent Designed to Treat Peripheral Vascular Lesions for Stenoses in Arteries above the Knee NATICK, Mass., Boston Scientific Corporation announces CE Mark and European market launch of the ...

Boston Scientific Corporation (NYSE: BSX) has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an advanced treatment option for patients with ...

Boston Scientific's FDA-approved Innova stent for PAD--Courtesy of Boston Scientific Boston Scientific ($BSX) announced FDA approval of its Innova Vascular Self ...

Medical device major Boston Scientific Corporation 's BSX self-expanding stent system - Innova Vascular - recently won marketing approval from the U.S. Food and Drug Administration (FDA). Subsequent ...

June 20, 2011 — Boston Scientific Corporation has recalled its Innova Self-Expanding Stent System for a potentially life-threatening defect, the US Food and Drug Administration (FDA) announced June 17 ...

The launch of the Innova stent will be of immense benefit to several patients as, according to estimates in Europe, Peripheral vascular disease (“PVD”) affects 13 million people or one in 20 people ...

NATICK, Mass., Aug. 19, 2013 /PRNewswire/ --Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the SuperNOVA trial - a global, single arm, prospective, multicenter trial evaluating ...

Please provide your email address to receive an email when new articles are posted on . Boston Scientific announced that it has received FDA approval for a self-expanding stent system to treat ...

Boston Scientific Corp. (NYSE: BSX) has recalled more than 500 stent systems in its second recall for a potentially life-threatening defect to be disclosed this week. The stent may fail to deploy or ...

MARLBOROUGH, Mass., Boston Scientific Corporation has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an advanced treatment option for ...